Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 309-318

  Holma, Reetta ^a   Salmenperä, Pertteli ^a   Riutta, Asko ^b   Virtanen, Ismo ^c   Korpela, Riitta ^a   Vapaatalo, Heikki ^a  

^a BIOMEDICUM HELSINKI   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cyclooxygenase 2; Cysteinyl leukotriene; Leukotriene B4; Montelukast; Prostaglandin E2; TNBS (trinitrobenzene sulphonic acid) induced colitis; Zileuton

Indexed keywords

CYCLOOXYGENASE 2; ICOSANOID; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR; MONTELUKAST; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TRINITROBENZENESULFONIC ACID; ZILEUTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG SCREENING; INCUBATION TIME; INFLAMMATION; MALE; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REDUCTION;

ACETATES; ANIMALS; COLITIS; CYCLOOXYGENASE 2; ISOENZYMES; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; MALE; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, LEUKOTRIENE; SEVERITY OF ILLNESS INDEX;

EID: 0035840814     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01330-9     Document Type: Article

References (62)

1. Adrenaline stimulates thromboxane and inhibits leukotriene synthesis in man
2. 2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation
3. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis
4. 4 release by unaffected jejunal mucosa in patients with inactive Crohn's disease
5. Leukotriene receptors and their antagonists
6. 4 synthesized by human alveolar macrophages
7. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro
8. Ketotifen effectively prevents mucosal damage in experimental colitis
9. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats
10. 4 synthesized by polymorphonuclear leukocytes
11. 4 metabolism
12. 4 in inflammation
13. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils
14. The reactivity of rat isolated gastrointestinal tissues to leukotrienes
15. Anti-inflammatory activity of phycocyanin extract in acetic acid-induced colitis in rats
16. Presence of immunocytes and sulfidopeptide leukotrienes in the inflamed guinea pig distal colon
17. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis
18. 4
19. Action of peptidoleukotrienes on ion transport in rabbit distal colon in vitro
20. Leukotriene generation by eosinophils
21. Induction of iNOS in a rat model of acute colitis
22. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-aminomethyl/benzyl] acetamidine
23. Effects of a COX-2 preferential agent nimesalide on TNBS-induced acute inflammation in the gut
24. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis
25. Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats
26. Inducible nitric oxide synthase: A little bit of good in all of us
27. Selective 5-lipoxygenase inhibition by zileuton in the treatment of relapsing ulcerative colitis: A randomized double-blind placebo-controlled multicentre trial
28. Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis
29. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology
30. Generation of leukotrienes by purified human lung mast cells
31. 4
32. 4, increase the release of mucus from human airways in vitro
33. Hapten-induced model of chronic inflammation and ulceration in the rat colon
34. Platelet-activating factor and interleukin 1 are involved in colonic dysmotility in experimental colitis in rats
35. Pharmacological aspects of 5-lipoxygenase inhibition
36. Treatment of eosinophilic gastroenteritis with montelukast
37. 4 antagonist on colonic damage induced by intracolonic administration of trinitrobenzene sulfonic acid in rats
38. Leukotrienes induce cell-survival signaling in intestinal epithelial cells
39. Review article: The potential role of nitric oxide in chronic inflammatory bowel disorders
40. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: Inhibition by sulfasalazine and 5-aminosalicylic acid
41. Possible mode of action of 5-aminosalicylic acid
42. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats
43. 4 participates in colonic transit disturbances induced by intracolonic administration of trinitrobenzene sulfonic acid in rats
44. Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase
45. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
46. Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man
47. Intestinal myoelectric response in two different models of acute enteric inflammation
48. Leukotrienes cause eosinophil emigration into conjunctival tissue
49. The tissue reaction in inflammatory bowel disease
50. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis
51. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis
52. Prostaglandin protection of rat colonic mucosa from damage induced by ethanol
53. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage?
54. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease
55. Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion
56. COX-1 and COX-2 products in the gut: Therapeutic impact of COX-2 inhibitors
57. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators
58. Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats?
59. 2 on human, porcine and guinea pig lung parenchyma
60. Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats
61. 4 in rabbit colitis. Relationship to inflammation
62. Chemotactic peptide stimulation of leukotrienes from healthy and inflamed rabbit colons